Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: Results from The TREAT Asia HIV Observational Database

• Main Authors: Zhou, J, Sirisanthana, T, Kiertiburanakul, S, Chen, Y.-M.A, Han, N, Lim, P.-L, Kumarasamy, N, Choi, J.Y, Merati, T.P, Yunihastuti, E, Oka, S, Kamarulzaman, A, Phanuphak, P, Lee, C.K.C, Li, P.C.K, Pujari, S, Saphonn, V, Law, M.G
• Other Authors: SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
• Format: Article
• Published: 2020
• Subjects: antiretrovirus agent; atazanavir; efavirenz plus lamivudine plus stavudine; efavirenz plus lamivudine plus zidovudine; indinavir; lamivudine plus nevirapine plus stavudine; lamivudine plus nevirapine plus zidovudine; lopinavir; nelfinavir; saquinavir; unclassified drug; adult; age distribution; article; CD4 lymphocyte count; concurrent infection; controlled study; data base; disease classification; female; hepatitis B; hepatitis C; HIV test; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; major clinical study; male; mixed infection; treatment duration; trend study; virus load; Asia; clinical trial; highly active antiretroviral therapy; immunology; multicenter study; statistical model; virology; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Linear Models; Male; Viral Load
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/181650
• Institution: National University of Singapore

10.1186/1471-2334-10-361